The ability to prevent such changes using a relatively inexpensive oral supplement such as alpha lipoic acid could significantly change the morbidity of diabetes in pet dogs where cataract development is a significant problem and in human patients with aldose reductase-related diabetic complications. This evidence concerns the gene AKR1B1 and diabetes mellitus.